IDV vehicle
75F40126D00023
IDIQ FOR PHARMACEUTICAL PRODUCTS FOR CDER RESEARCH STUDIES. INCLUDES BRAND NAME AND/OR GENERIC PHARMACEUTICALS TO INCLUDE SMALL MOLECULE AND PEPTIDE THERAPEUTICS, DRUG-DEVICE COMBINATION PRODUCTS, AND CONTRAST AGENTS. EO 14398
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $99.9K |
| Current contract value | Not reported |
| Potential contract value / ceiling | $4.0M |
| Start date | Sep 15, 2026 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 11, 2026 | 0 | $99.9K | IDIQ FOR PHARMACEUTICAL PRODUCTS FOR CDER RESEARCH STUDIES. INCLUDES BRAND NAME AND/OR GENERIC PHARMACEUTICALS TO INCLUDE SMALL MOLECULE AND PEPTIDE THERAPEUTICS, DRUG-DEVICE COMBINATION PRODUCTS, AND CONTRAST AGENTS. EO 14398 |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.